JADPRO 2022

Conference Coverage

Biomarker Test Reports Should Be More Patient- and Provider-Friendly

Researchers sought to identify the challenges that patients and healthcare providers experience with understanding and using biomarker test results.

Recurrences and Deaths Prevented by Atezolizumab Translate to Lower Cost of Care

Adjuvant atezolizumab can prevent recurrence and death, thereby reducing costs, in patients with early non-small cell lung cancer, a study suggests.

Strategies for VTE Prophylaxis in Cancer for Inpatient, Outpatient Settings

Recommendations for venous thromboembolism prophylaxis in patients with cancer were discussed in an oral session at JADPRO Live 2022.

Undetectable PSA Levels Tied to Improvements in rPFS, OS in Metastatic Hormone-Sensitive Prostate Cancer

Patients with mHSPC who receive enzalutamide plus ADT are 4 times more likely to achieve undetectable PSA levels than patients who receive ADT alone, according to an analysis of data from the ARCHES trial.

More Resources Needed for African-American Women Who Survive Breast Cancer

African-American women who survive breast cancer do not get adequate resources to support their mental and emotional health, a small study suggests.

Risk of VTE 6-Fold Higher in CLL/MBL Than in General Population

Patients with chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis have an increased risk of venous thromboembolism, a study suggests.

Still Unclear Whether Intermittent Fasting Can Improve Cancer Outcomes

Intermittent fasting appears safe as an adjunct to chemotherapy, but it is unclear whether this diet can improve cancer outcomes.

Palbociclib Improves Outcomes of HR+/HER2- Metastatic Breast Cancer in Real World

Real-world data support first-line palbociclib plus an aromatase inhibitor as standard care for HR+, HER2- metastatic breast cancer, according to researchers.

Simulation With Task Trainers Improved BMT Procedure Skills, Knowledge

A poster presentation at JADPRO Live 2022 described the benefits of using simulation training in combination with didactic educational sessions to improve knowledge and confidence for bone marrow transplant APPs.

Cost and Coordination of Care Head List of Concerns With Combination IV/Oral Therapy

Results of an ACCC study revealed advanced practitioners’ greatest challenges when treating cancer patients with combination IV/oral therapies.